These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7272787)

  • 1. Changes in brain norepinephrine content in mice following neonatal 6-hydroxydopamine.
    Lovell KL
    Brain Res Bull; 1981 Jul; 7(1):41-4. PubMed ID: 7272787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal intraspinal 6-hydroxydopamine: depletion of norepinephrine but not dopamine.
    Ings R; Pappas B
    Eur J Pharmacol; 1981 Apr; 70(4):577-83. PubMed ID: 6263641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional development of norepinephrine, dopamine-beta-hydroxylase and tyrosine hydroxylase in the rat brain subsequent to neonatal treatment with subcutaneous 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Apr; 166(2):293-308. PubMed ID: 34468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biochemical and morphological study of the altered growth pattern of central catecholamine neurons following 6-hydroxydopamine.
    Konkol RJ; Bendeich EG; Breese GR
    Brain Res; 1978 Jan; 140(1):125-35. PubMed ID: 626876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of hypertrophied locus coeruleus projection to adult cerebellum after neonatal 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Aug; 172(1):23-33. PubMed ID: 466465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 6-hydroxydopamine-induced norepinephrine depletion on cerebellar development.
    Lovell KL
    Dev Neurosci; 1982; 5(4):359-68. PubMed ID: 6814890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracisternal dose-response analysis of 6-hydroxydopamine-induced noradrenergic sprouting in the neonatal rat cerebellum.
    Schmidt RH; Bhatnagar RK
    J Pharmacol Exp Ther; 1980 Mar; 212(3):456-61. PubMed ID: 7359347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny.
    Sachs C; Jonsson G
    Brain Res; 1975 Dec; 99(2):277-91. PubMed ID: 1182547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of selective depletion of brain regional noradrenaline by systemic 6-hydroxydopamine in newborn rats.
    Liew MC; Laverty R
    Eur J Pharmacol; 1975 Aug; 33(1):165-72. PubMed ID: 1175683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testicular function after local injection of 6-hydroxydopamine or norepinephrine in the golden hamster (Mesocricetus auratus).
    Mayerhofer A; Amador AG; Steger RW; Bartke A
    J Androl; 1990; 11(3):301-11. PubMed ID: 2117002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersensitivity of the noradrenergic system in the spinal cord following intracisternal injection of 6-hydroxydopamine.
    Jones DJ; Alcantara OF; Ademe RM
    Neuropharmacology; 1984 Apr; 23(4):431-8. PubMed ID: 6145115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerative critical periods for locus coeruleus in postnatal rat pups following intracisternal 6-hydroxydopamine: a model of noradrenergic development.
    Schmidt RH; Kasik SA; Bhatnagar RK
    Brain Res; 1980 Jun; 191(1):173-90. PubMed ID: 7378749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal 6-hydroxydopamine alters the behavior of enriched-impoverished rats in a novel test environment.
    Saari MJ; Armstrong JN; Nobrega JN; Pappas BA; Coscina DV
    Behav Neurosci; 1990 Jun; 104(3):430-7. PubMed ID: 2112942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kindling antagonism: a role for hindbrain norepinephrine in the development of site suppression following concurrent, alternate stimulation.
    Applegate CD; Konkol RJ; Burchfiel JL
    Brain Res; 1987 Mar; 407(2):212-22. PubMed ID: 3105818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of brainstem norepinephrine in pentylenetetrazol convulsions in rats.
    Oishi R; Suenaga N; Fukuda T
    Pharmacol Biochem Behav; 1979 Jan; 10(1):57-61. PubMed ID: 441096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stages of recovery from central norepinephrine lesions in enriched and impoverished environments: a behavioral and biochemical study.
    Diaz J; Ellison G; Masouka D
    Exp Brain Res; 1978 Jan; 31(1):117-30. PubMed ID: 639905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered responsiveness of adenosine 3',5'-monophosphate-generating systems in brain slices from adult rats after neonatal treatment with 6-hydroxydopamine.
    Dismukes RK; Daly JW
    Exp Neurol; 1975 Oct; 49(1 Pt 1):150-60. PubMed ID: 171170
    [No Abstract]   [Full Text] [Related]  

  • 19. Alteration of seizures resulting from pinealectomy in the rat after neonatal treatment with 6-hydroxydopamine.
    Stockmeier CA; Larsen BR; Blask DE
    J Neurosci Res; 1985; 14(2):279-84. PubMed ID: 3930758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine hydroxylase activity in brain regions after intraventricular 6-hydroxydopamine in the neonatal rat.
    Peters DA; Pappas BA; Taub H; Saari M
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):161-4. PubMed ID: 28554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.